[The role of the immune system in the pathogenesis and treatment of suppurative-inflammatory diseases after cesarean section].
Timoshenko
L V
LV
Vdovichenko
Iu P
IuP
D000276:Adjuvants, Immunologic / Q000627:therapeutic use; D001424:Bacterial Infections / Q000188:drug therapy / Q000209:etiology* / Q000276:immunology; D002585:Cesarean Section / Q000009:adverse effects*; D004716:Endometritis / Q000188:drug therapy / Q000209:etiology* / Q000276:immunology; D005260:Female; D006801:Humans; D007108:Immune Tolerance / Q000187:drug effects / Q000276:immunology*; D007978:Levamisole / Q000627:therapeutic use; D009894:Opportunistic Infections / Q000188:drug therapy / Q000209:etiology* / Q000276:immunology; D010455:Peptides / Q000627:therapeutic use; D011247:Pregnancy; D013530:Surgical Wound Infection / Q000188:drug therapy / Q000209:etiology* / Q000276:immunology; D013949:Thymus Extracts / Q000627:therapeutic use
D000276:Adjuvants, Immunologic; D010455:Peptides; D013949:Thymus Extracts; D007978:Levamisole; C036191:T-activin
Rol' immunnoĭ sistemy v patogeneze i lechenii gnoĭno-vospalitel'- nykh zabolevaniĭ posle operatsii kesareva secheniia.